News
-
-
-
COMMUNIQUÉ DE PRESSE
Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results -
-
-
COMMUNIQUÉ DE PRESSE
Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus
